トルコで最高の胆嚢癌医師 - トップ46名の医師

Dr. Bülent Karagöz は、腫瘍生物学および免疫療法を専門とする、33年の経験 以上の経験を持つトルコのトップ腫瘍内科医です。

• アナドル医療センター腫瘍内科部長
• イスタンブール・オカン大学医学部教授
• がん研究分野における40本以上の論文発表
• トルコ腫瘍内科学会会員

タンルクル医師は、腫瘍内科における国際的な臨床試験を主導し、消化器がんの化学療法を専門としています。

• 腫瘍内科における21年の経験以上の臨床経験を有する
• マルマラ大学の腫瘍内科プログラム（上位ランク）にて研修を修了
• 主要な研究病院にて腫瘍内科部門の部長を歴任
• 内科および腫瘍内科の両分野において専門医研修を修了

イルケル・ティナイ医師は、泌尿器腫瘍専門医であり、低侵襲手術、新膀胱再建術、および泌尿器悪性腫瘍の治療を専門としています。アナドル医療センターに勤務しており、イスタンブール大学を卒業後、マルマラ大学にて泌尿器科の専門医研修を修了しました。

ティナイ医師は、泌尿器腫瘍学会の理事、膀胱腫瘍研究グループの幹事、および泌尿器外科学会（北マルマラ）の評議員を務めています。また、欧州泌尿器科学会およびアメリカ外科学会の会員でもあります。

胆嚢癌を含む消化器癌を専門とし、ハジェテペ大学癌研究所およびMDアンダーソン癌センターにて研鑽を積む。

• トルコ有数の癌研究所にてフェローシップを修了
• 複数の癌種にわたる複雑な症例を経験
• 権威あるMDアンダーソン癌センターにて研修を受講
• 有数の医療施設であるヒサール・ホスピタル・インターコンチネンタルにて診療に従事

ペケル教授は、ヒサール・ホスピタル・インターコンチネンタルにおける肝胆膵外科を専門とし、400件以上の膵臓がん・胃がん手術を執刀してきました。

• メイヨー・クリニックにて肝胆膵外科のトレーニングを修了
• バクルキョイ・ドクター・サディ・コヌク研修研究病院における肝胆膵外科ユニットの創設者
• 胆嚢および胆管疾患の外科治療を専門とする
• 200件以上の肝臓手術を執刀

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Dr. Yahya Özel is a highly experienced general surgeon with expertise in bariatric surgery, hepatobiliary diseases, abdominal hernias, endocrine surgery, and oncological surgery. He completed his medical education at Istanbul University, Istanbul Faculty of Medicine in 1990 and pursued his specialization in General Surgery at Haydarpaşa Numune Training and Research Hospital between 2001 and 2006. His commitment to advanced surgical techniques led him to further training at Tokyo University Hospital, Japan, in the Hepato-Biliary-Pancreatic Surgery and Artificial Organ Division under renowned experts M. Makuuchi and N. Kokudo.

Throughout his career, Dr. Özel has worked at prestigious institutions, including Istanbul University Faculty of Medicine, Haydarpaşa Numune Training and Research Hospital, and Ümraniye Training and Research Hospital. His extensive experience includes roles in ERCP and surgical endoscopy, as well as advanced laparoscopic and robotic surgery. In addition to his clinical practice, he has served as an academic faculty member at Doğuş University, contributing to the education and training of future medical professionals.

Dr. Özel holds several certifications in surgical endoscopy, including the Turkish Surgical Proficiency Certificate. His dedication to minimally invasive surgical techniques, obesity treatment, and hepatobiliary surgery has made him a sought-after specialist in his field. With a career spanning over three decades, he continues to provide high-quality, patient-centered surgical care, ensuring the best outcomes through his expertise and innovative approach.

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

シナン・カラアスラン医師は、アナドル・メディカルセンターの腫瘍内科医です（2014年より在籍）。乳癌、大腸癌、泌尿生殖器系腫瘍の治療を専門とし、腫瘍内科における臨床経験は2003年より積んでいます。トルコ医師会、トルコ腫瘍内科学会、トルコ肺癌学会の会員です。

患者様がカラアスラン医師を選び、信頼する理由：

• 乳癌・大腸癌・泌尿生殖器系腫瘍の難症例を担当し、腫瘍の種類と病期に応じた最新の全身療法を適用しています。
• トルコ医師会、トルコ腫瘍内科学会、トルコ肺癌学会の会員です。
• 化学療法および免疫療法に関する多数の学術論文および患者向け教育資料の著者です。
• 同医師が勤務するセンターはESMO指定センターの認定を受け、JCI認証を取得しており、米国の主要医療機関の一つであるジョンズ・ホプキンス・メディシン・インターナショナルと戦略的提携を結んでいます。患者様にとって、これは米国の診療プロトコルに基づく治療と最新医療機器の活用を意味します。

腫瘍内科専門医資格試験においてトルコ全国第1位を獲得したケスキン医師は、メモリアル・シシリ病院において25年の経験の経験を胆嚢がん治療に活かしています。

• イスタンブール大学腫瘍学研究所にて腫瘍内科専門研修を修了
• 米国臨床腫瘍学会（ASCO）および欧州腫瘍内科学会（ESMO）会員
• 第19回全国がん学会にてベストポスター賞を受賞
• 化学療法、分子標的療法、免疫療法などの先進的治療法を駆使

Yildirim教授は、アナドル医療センターでがん免疫療法および分子標的療法を専門としています。また、『先進がん治療ハンドブック』の共著者でもあります。

• 2011年のセンター着任以来、10年以上にわたる腫瘍内科診療の経験を有する
• 国内外の学術論文・著書を80編以上執筆
• 胆嚢がんを含む消化器がんの治療を担当
• 欧州臨床腫瘍学会（ESMO）認定資格を保有
• ロンドンのマウント・バーノンがんセンターにて専門研修を修了

シェレフ・ケミュルキュ教授は、ECFMG及びESMO認定の乳腺腫瘍専門医であり、20年以上の診療経験を有しています。固形がん、乳がん、大腸がん、肺がんの治療を専門とし、キャリアを通じて教育・研究職を歴任してきました。複数の専門職能団体の会員でもあります。

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.